An oral GLP-1 and GIP dual receptor agonist improves metabolic disorders in high fat-fed mice-Reference-Cited by-同舟云学术

An oral GLP-1 and GIP dual receptor agonist improves metabolic disorders in high fat-fed mice

Published:2022-01 Issue: Volume:914 Page:174635
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Ma Teng^ORCID,Lu Weisheng,Wang Yongkang,Qian Peng,Tian Hong,Gao Xiangdong,Yao Wenbing

Funder

National Natural Science Foundation of China

Double First Class University Plan

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

Elsevier BV

Subject

Pharmacology

Reference38 articles.

1. Absorption-enhancing effects of gemini surfactant on the intestinal absorption of poorly absorbed hydrophilic drugs including peptide and protein drugs in rats;Alama;Int. J. Pharm.,2016

2. Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function;Juan Pablo Botero Aguirre;Cochrane Database Syst. Rev.,2015

3. Design of novel exendin-based dual glucagon-like peptide 1 (GLP-1)/Glucagon receptor agonists;Andreas;J. Med. Chem.,2017

4. Dual glucagon-like peptide 1 (GLP-1)/Glucagon receptor agonists specifically optimized for multidose formulations;Andreas;J. Med. Chem.,2018

5. GIP analogues and the treatment of obesity-diabetes;Bailey;Peptides,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity;Expert Opinion on Investigational Drugs;2024-07-17

2. Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism;Diabetes & Metabolism Journal;2024-05-31

3. Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature;International Journal of Molecular Sciences;2024-03-29

4. The chylomicron saga: time to focus on postprandial metabolism;Frontiers in Endocrinology;2024-01-18

5. GIPR Agonism Enhances TZD-Induced Insulin Sensitivity in Obese IR Mice;Diabetes;2023-11-07